Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
10 2021
Historique:
received: 16 05 2021
accepted: 16 08 2021
pubmed: 29 9 2021
medline: 26 10 2021
entrez: 28 9 2021
Statut: ppublish

Résumé

In Africa, most rapid diagnostic tests (RDTs) for falciparum malaria recognize histidine-rich protein 2 antigen. Plasmodium falciparum parasites lacking histidine-rich protein 2 (pfhrp2) and 3 (pfhrp3) genes escape detection by these RDTs, but it is not known whether these deletions confer sufficient selective advantage to drive rapid population expansion. By studying blood samples from a cohort of 12,572 participants enroled in a prospective, cross-sectional survey along Ethiopia's borders with Eritrea, Sudan and South Sudan using RDTs, PCR, an ultrasensitive bead-based immunoassay for antigen detection and next-generation sequencing, we estimate that histidine-rich protein 2-based RDTs would miss 9.7% (95% confidence interval 8.5-11.1) of P. falciparum malaria cases owing to pfhrp2 deletion. We applied a molecular inversion probe-targeted deep sequencing approach to identify distinct subtelomeric deletion patterns and well-established pfhrp3 deletions and to uncover recent expansion of a singular pfhrp2 deletion in all regions sampled. We propose a model in which pfhrp3 deletions have arisen independently multiple times, followed by strong positive selection for pfhrp2 deletion owing to RDT-based test-and-treatment. Existing diagnostic strategies need to be urgently reconsidered in Ethiopia, and improved surveillance for pfhrp2 deletion is needed throughout the Horn of Africa.

Identifiants

pubmed: 34580442
doi: 10.1038/s41564-021-00962-4
pii: 10.1038/s41564-021-00962-4
pmc: PMC8478644
mid: NIHMS1733833
doi:

Substances chimiques

Antigens, Protozoan 0
HRP-2 antigen, Plasmodium falciparum 0
HRP3 protein, Plasmodium falciparum 0
Protozoan Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1289-1299

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI134990
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007168
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI132547
Pays : United States
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund)
ID : EPHI5405

Informations de copyright

© 2021. The Author(s).

Références

False-negative RDT Results and Implications of New Reports of P. falciparum Histidine-rich Protein 2/3 Gene Deletions (World Health Organization, 2016).
Verma, A. K., Bharti, P. K. & Das, A. HRP-2 deletion: a hole in the ship of malaria elimination. Lancet Infect. Dis. 18, 826–827 (2018).
pubmed: 30064667 doi: 10.1016/S1473-3099(18)30420-1
Wellems, T. E. & Howard, R. J. Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc. Natl Acad. Sci. USA 83, 6065–6069 (1986).
pubmed: 3016741 pmcid: 386439 doi: 10.1073/pnas.83.16.6065
Howard, R. J. et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J. Cell Biol. 103, 1269–1277 (1986).
pubmed: 3533951 doi: 10.1083/jcb.103.4.1269
Li, B. et al. Performance of pfHRP2 versus pLDH antigen rapid diagnostic tests for the detection of Plasmodium falciparum: a systematic review and meta-analysis. Arch. Med. Sci. 13, 541–549 (2017).
pubmed: 28507567 pmcid: 5420633 doi: 10.5114/aoms.2017.67279
Baker, J. et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J. Infect. Dis. 192, 870–877 (2005).
pubmed: 16088837 doi: 10.1086/432010
Good Practices for Selecting and Procuring Rapid Diagnostic Tests for Malaria (World Health Organization, 2011).
Cheng, Q. et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar. J. 13, 283 (2014).
pubmed: 25052298 pmcid: 4115471 doi: 10.1186/1475-2875-13-283
Poti, K. E., Sullivan, D. J., Dondorp, A. M. & Woodrow, C. J. HRP2: transforming malaria diagnosis, but with caveats. Trends Parasitol. 36, 112–126 (2020).
pubmed: 31848119 doi: 10.1016/j.pt.2019.12.004
Gamboa, D. et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE 5, e8091 (2010).
pubmed: 20111602 pmcid: 2810332 doi: 10.1371/journal.pone.0008091
Grignard, L. et al. A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in oolyclonal infections. EBioMedicine 55, 102757 (2020).
pubmed: 32403083 pmcid: 7218259 doi: 10.1016/j.ebiom.2020.102757
Plucinski, M. M. et al. Screening for Pfhrp2/3-deleted Plasmodium falciparum, non-falciparum, and low-density malaria infections by a multiplex antigen assay. J. Infect. Dis. 219, 437–447 (2019).
pubmed: 30202972 doi: 10.1093/infdis/jiy525
Parr, J. B., Anderson, O., Juliano, J. J. & Meshnick, S. R. Streamlined, PCR-based testing for pfhrp2- and pfhrp3-negative Plasmodium falciparum. Malar. J. 17, 137 (2018).
pubmed: 29609602 pmcid: 5879555 doi: 10.1186/s12936-018-2287-4
Berhane, A. et al. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea. Emerg. Infect. Dis. 24, 462–470 (2018).
pubmed: 29460730 pmcid: 5823352 doi: 10.3201/eid2403.171723
Akinyi, S. et al. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci. Rep. 3, 2797 (2013).
pubmed: 24077522 pmcid: 3786299 doi: 10.1038/srep02797
Parr, J. B. et al. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey. J. Infect. Dis. 216, 36–44 (2017).
pubmed: 28177502 doi: 10.1093/infdis/jix347
Sepúlveda, N. et al. Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2) and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis. Infect. Genet. Evol. 62, 211–219 (2018).
pubmed: 29729386 doi: 10.1016/j.meegid.2018.04.039
Gibbons, J. et al. Lineage-specific expansion of Plasmodium falciparum parasites with pfhrp2 deletion in the Greater Mekong subregion. J. Infect. Dis. 222, 1561–1569 (2020).
pubmed: 32386321 pmcid: 7529045 doi: 10.1093/infdis/jiaa250
MalariaGEN et al.An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Res. 6, 42 (2021).
pmcid: 8008441 doi: 10.12688/wellcomeopenres.16168.2
Otto, T. D. et al. Long read assemblies of geographically dispersed Plasmodium falciparum isolates reveal highly structured subtelomeres. Wellcome Open Res. 3, 52 (2018).
pubmed: 29862326 pmcid: 5964635 doi: 10.12688/wellcomeopenres.14571.1
World Health Organization. False-negative RDT results and implications of new P. falciparum histidine-rich protein 2/3 gene deletions (WHO, 2016).
Menegon, M. et al. Identification of Plasmodium falciparum isolates lacking histidine-rich protein 2 and 3 in Eritrea. Infect. Genet. Evol. 55, 131–134 (2017).
pubmed: 28889944 doi: 10.1016/j.meegid.2017.09.004
Thomson, R. et al. Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review. Bull. World Health Organ. 98, 558–568F (2020).
pubmed: 32773901 pmcid: 7411324 doi: 10.2471/BLT.20.250621
Golassa, L., Messele, A., Amambua-Ngwa, A. & Swedberg, G. High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia. PLoS ONE 15, e0241807 (2020).
pubmed: 33152025 pmcid: 7644029 doi: 10.1371/journal.pone.0241807
Gefen-Halevi, S. et al. HRP2/3 mutation in recrudescent Plasmodium falciparum malaria case acquired in Ethiopia. J. Travel Med. 28, taaa196 (2020).
doi: 10.1093/jtm/taaa196
Alemayehu, G. S. et al. Detection of high prevalence of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Assosa zone, Ethiopia: implication for malaria diagnosis. Malar. J. 20, 109 (2021).
pubmed: 33622309 pmcid: 8095343 doi: 10.1186/s12936-021-03629-x
National Malaria Elimination Roadmap (Federal Democratic Republic of Ethiopia Ministry of Health, 2017).
World Malaria Report 2019 (World Health Organization, 2019); https://www.who.int/publications/i/item/world-malaria-report-2019
Taffese, H. S. et al. Malaria epidemiology and interventions in Ethiopia from 2001 to 2016. Infect. Dis. Poverty 7, 103 (2018).
pubmed: 30392470 pmcid: 6217769 doi: 10.1186/s40249-018-0487-3
Template Protocols to Support Surveillance and Research for pfhrp2/pfhrp3 Gene Deletions (World Health Organization, 2020); https://www.who.int/malaria/publications/atoz/hrp2-deletion-protocol/en/
Morgan, A. P. et al. Falciparum malaria from coastal Tanzania and Zanzibar remains highly connected despite effective control efforts on the archipelago. Malar. J. 19, 47 (2020).
pubmed: 31992305 pmcid: 6988337 doi: 10.1186/s12936-020-3137-8
Parr, J. B. et al. Analysis of false-negative rapid diagnostic tests for symptomatic malaria in the Democratic Republic of the Congo. Sci. Rep. 11, 6495 (2021).
Aydemir, O. et al. Drug-resistance and population structure of Plasmodium falciparum across the Democratic Republic of Congo using high-throughput molecular inversion probes. J. Infect. Dis. 218, 946–955 (2018).
pubmed: 29718283 pmcid: 6093412 doi: 10.1093/infdis/jiy223
Nunes, M. C., Okada, M., Scheidig-Benatar, C., Cooke, B. M. & Scherf, A. Plasmodium falciparum FIKK kinase members target distinct components of the erythrocyte membrane. PLoS ONE 5, e11747 (2010).
pubmed: 20668526 pmcid: 2909202 doi: 10.1371/journal.pone.0011747
Jaskiewicz, E., Jodłowska, M., Kaczmarek, R. & Zerka, A. Erythrocyte glycophorins as receptors for Plasmodium merozoites. Parasit. Vectors 12, 317 (2019).
pubmed: 31234897 pmcid: 6591965 doi: 10.1186/s13071-019-3575-8
Sabeti, P. C. et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 419, 832–837 (2002).
pubmed: 12397357 doi: 10.1038/nature01140
Malaria Rapid Diagnostic Test Performance: Summary Results of WHO Product Testing of Malaria RDTs: Round 1-8 (2008–2018) (World Health Organization, 2018).
Berhane, A. et al. Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results. Malar. J. 16, 105 (2017).
pubmed: 28264689 pmcid: 5339986 doi: 10.1186/s12936-017-1752-9
Boush, M. A. et al. Plasmodium falciparum isolate with histidine-rich protein 2 gene deletion from Nyala City, Western Sudan. Sci. Rep. 10, 12822 (2020).
pubmed: 32733079 pmcid: 7393171 doi: 10.1038/s41598-020-69756-8
Cunningham, J. Tracking the global distribution and prevalence of pfhrp2/3 gene deletions. In Tropical Medicine 2020, Annual Meeting of the American Society for Tropical Medicine and Hygiene, Symposium 167 (2020).
Gatton, M. L. et al. Implications of parasites lacking Plasmodium falciparum histidine-rich protein 2 on malaria morbidity and control when rapid diagnostic tests are used for diagnosis. J. Infect. Dis. 215, 1156–1166 (2017).
pubmed: 28329034 doi: 10.1093/infdis/jix094
Watson, O. J. et al. Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa. eLife 6, e25008 (2017).
pubmed: 28837020 pmcid: 5602420 doi: 10.7554/eLife.25008
Watson, O. J. et al. Impact of seasonal variations in Plasmodium falciparum malaria transmission on the surveillance of pfhrp2 gene deletions. eLife 8, e40339 (2019).
pubmed: 31045490 pmcid: 6533063 doi: 10.7554/eLife.40339
Kong, A. et al. HRP2 and HRP3 cross-reactivity and implications for HRP2-based RDT use in regions with Plasmodium falciparum hrp2 gene deletions. Malar. J. 20, 207 (2021).
pubmed: 33926477 pmcid: 8086288 doi: 10.1186/s12936-021-03739-6
Pal, P. et al. Plasmodium falciparum histidine-rich protein II compromises brain endothelial barriers and may promote cerebral malaria pathogenesis. mBio 7, e00617-16 (2016).
pubmed: 27273825 pmcid: 4959673 doi: 10.1128/mBio.00617-16
Pal, P. et al. Plasmodium falciparum histidine-rich protein II causes vascular leakage and exacerbates experimental cerebral malaria in mice. PLoS ONE 12, e0177142 (2017).
pubmed: 28475625 pmcid: 5419595 doi: 10.1371/journal.pone.0177142
Leffler, E. M. et al. Resistance to malaria through structural variation of red blood cell invasion receptors.Science 356, eaam639 (2017).
doi: 10.1126/science.aam6393
Saito, F. et al. Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors. Nature 552, 101–105 (2017).
pubmed: 29186116 pmcid: 5748893 doi: 10.1038/nature24994
Niang, M. et al. STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting. Cell Host Microbe 16, 81–93 (2014).
pubmed: 25011110 pmcid: 4382205 doi: 10.1016/j.chom.2014.06.004
National Malaria Guidelines (Federal Democratic Republic of Ethiopia Ministry of Health, 2017); https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/eth_national_malaria_guidline_4th_edition.pdf
Plowe, C. V., Djimde, A., Bouare, M., Doumbo, O. & Wellems, T. E. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52, 565–568 (1995).
pubmed: 7611566 doi: 10.4269/ajtmh.1995.52.565
Pickard, A. L. et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47, 2418–2423 (2003).
pubmed: 12878499 pmcid: 166057 doi: 10.1128/AAC.47.8.2418-2423.2003
MIPTools. GitHub https://github.com/bailey-lab/MIPTools (2021).
Verity, R. et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11, 2107 (2020).
pubmed: 32355199 pmcid: 7192906 doi: 10.1038/s41467-020-15779-8
MIPWrangler GitHub https://github.com/bailey-lab/MIPWrangler (2020).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
Oyola, S. O. et al. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification. Malar. J. 15, 597 (2016).
pubmed: 27998271 pmcid: 5175302 doi: 10.1186/s12936-016-1641-7
Miles, A. et al. Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum. Genome Res. 26, 1288–1299 (2016).
pubmed: 27531718 pmcid: 5052046 doi: 10.1101/gr.203711.115
Gautier, M. & Vitalis, R. rehh: an R package to detect footprints of selection in genome-wide SNP data from haplotype structure. Bioinformatics 28, 1176–1177 (2012).
pubmed: 22402612 doi: 10.1093/bioinformatics/bts115
Chang, H. H. et al. THE REAL McCOIL: a method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites. PLoS Comput. Biol. 13, e1005348 (2017).
pubmed: 28125584 pmcid: 5300274 doi: 10.1371/journal.pcbi.1005348

Auteurs

Sindew M Feleke (SM)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia. sindewm@gmail.com.

Emily N Reichert (EN)

Institute for Global Health and Infectious Diseases, Department of Medicine, Division of Infectious Diseases and Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Hussein Mohammed (H)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Bokretsion G Brhane (BG)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Kalkidan Mekete (K)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Hassen Mamo (H)

Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Beyene Petros (B)

Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Hiwot Solomon (H)

Ministry of Health, Addis Ababa, Ethiopia.

Ebba Abate (E)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Chris Hennelly (C)

Institute for Global Health and Infectious Diseases, Department of Medicine, Division of Infectious Diseases and Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Madeline Denton (M)

Institute for Global Health and Infectious Diseases, Department of Medicine, Division of Infectious Diseases and Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Corinna Keeler (C)

Institute for Global Health and Infectious Diseases, Department of Medicine, Division of Infectious Diseases and Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Nicholas J Hathaway (NJ)

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Jonathan J Juliano (JJ)

Institute for Global Health and Infectious Diseases, Department of Medicine, Division of Infectious Diseases and Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Jeffrey A Bailey (JA)

Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.

Eric Rogier (E)

Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Jane Cunningham (J)

Global Malaria Programme, World Health Organization, Geneva, Switzerland. cunninghamj@who.int.

Ozkan Aydemir (O)

Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.

Jonathan B Parr (JB)

Institute for Global Health and Infectious Diseases, Department of Medicine, Division of Infectious Diseases and Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jonathan_parr@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH